Aelan Cell Technologies Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

Aelan Cell Technologies General Information

Description

Developer of cell-based therapies intended to deliver new medicines and diagnostics to patients. The company provides a suite of software tools that help to manage the complex process of cell therapy manufacturing, storage, and delivery and also includes a network of qualified cell therapy providers, enabling the cell therapy market to reach more patients and improve patient outcomes.

Contact Information

Website
www.aelanct.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • 665 3rd Street
  • San Francisco, CA 94107
  • United States
+1 (415) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelan Cell Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Jun-2015 Completed Startup
To view Aelan Cell Technologies’s complete valuation and funding history, request access »

Aelan Cell Technologies Patents

  • 28

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Aelan Cell Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3700569-A4 H1.0k180me2 antibodies, methods of making and uses thereof Pending 25-Oct-2017 000000000 0
EP-3700569-A1 H1.0k180me2 antibodies, methods of making and uses thereof Pending 25-Oct-2017 000000000
JP-2023052165-A H1.0k180me2 antibodies, methods of making and using them Pending 25-Oct-2017 000000000
US-20200362056-A1 H1.0k180me2 antibodies, methods of making and uses thereof Active 25-Oct-2017 000000000 0
US-11505621-B2 H1.0k180me2 antibodies, methods of making and uses thereof Active 25-Oct-2017 C07K16/44 00
To view Aelan Cell Technologies’s complete patent history, request access »

Aelan Cell Technologies Executive Team (3)

Name Title Board Seat Contact Info
Victoria Lunyak Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Chester Aldridge Co-Founder & Chairman
Walter Afanasieff Co-Founder
To view Aelan Cell Technologies’s complete executive team members history, request access »

Aelan Cell Technologies Board Members (1)

Name Representing Role Since
Chester Aldridge Aelan Cell Technologies Co-Founder & Chairman 000 0000
To view Aelan Cell Technologies’s complete board members history, request access »

Aelan Cell Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial